A historic shift in Canadian drug policy has taken place, as the government allow the use of psilocybin fungi for therapeutic applications. Previously, these substances were heavily restricted, but a mounting body of evidence suggests they may offer relief for emotional illnesses like anxiety. This development represents a substantial step toward r